van Mackelenbergh MT, Loibl S, Untch M, Buyse M, et al. Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant Chemotherapy Plus Anti-Human Epidermal Growth Factor Receptor 2 Therapy of Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer. J Clin Oncol 2023 Apr 19:JCO2202241. doi: 10.1200/JCO.22.02241.
PMID: 37075276